Codes / ICD10CM / D57.813

D57.813 Other sickle-cell disorders with cerebral vascular involvement

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other sickle-cell disorders with cerebral vascular involvement

Summary

Other sickle-cell disorders with cerebral vascular involvement represent a subtype of inherited blood conditions characterized by abnormal hemoglobin, leading to red blood cells that assume a rigid, sickle shape. These malformed cells can obstruct blood flow, resulting in pain, organ damage, and other complications. The presence of cerebral vascular involvement indicates a severe manifestation affecting the brain's blood vessels, distinguishing this subtype from stable forms of the disorder.

Causes

Other sickle-cell disorders arise from mutations in the hemoglobin gene (HBB), which alters hemoglobin structure. These genetic mutations follow an autosomal recessive inheritance pattern, requiring two copies of the mutated gene (one from each parent) for the disorder to develop. Cerebral vascular involvement occurs when sickled red blood cells obstruct blood flow in the brain, potentially leading to ischemia or hemorrhage.

Risk Factors

  • Family history of sickle-cell disorders
  • Ethnic background, particularly individuals of African, Mediterranean, Middle Eastern, Indian, or Caribbean descent
  • Inheriting one sickle-cell gene (sickle cell trait) increases the risk of passing the disorder to offspring
  • Prior episodes of cerebrovascular events
  • Chronic anemia or increased blood viscosity

Symptoms

  • Sudden severe headache
  • Weakness or numbness on one side of the body
  • Difficulty speaking or understanding speech
  • Visual disturbances
  • Dizziness or loss of balance
  • Seizures
  • Altered mental status or confusion

Diagnosis

Diagnosis involves blood tests to identify abnormal hemoglobin and confirm sickle-cell disease. Imaging studies, such as MRI or CT scans, assess cerebral blood flow and detect vascular abnormalities. Additional tests may include transcranial Doppler to evaluate blood flow in cerebral arteries and cerebrospinal fluid analysis if stroke is suspected.

Treatment Options

Treatment focuses on managing acute events and preventing recurrence. Acute care may include oxygen therapy, hydration, and blood transfusions to improve oxygen delivery. Long-term management involves hydroxyurea to reduce sickling, regular blood transfusions, and medications to control blood pressure. In some cases, surgical interventions or stem cell transplantation may be considered.

Prognosis and Follow-Up

Prognosis depends on the severity of cerebral involvement and timeliness of treatment. Early intervention improves outcomes, but recurrent events can lead to permanent neurological damage. Regular follow-up with hematologists and neurologists is essential to monitor for complications and adjust treatment plans. Lifelong management is typically required.

Complications

  • Ischemic or hemorrhagic stroke
  • Cognitive impairment or learning disabilities
  • Recurrent cerebrovascular events
  • Seizure disorders
  • Permanent neurological deficits

Lifestyle & Prevention

  • Maintain adequate hydration to reduce blood viscosity
  • Avoid extreme temperatures and high altitudes
  • Follow prescribed medication regimens consistently
  • Attend regular medical check-ups for monitoring
  • Engage in age-appropriate physical activity with medical guidance
  • Educate family members about recognizing stroke symptoms

When to Seek Professional Help

Seek immediate medical attention for sudden severe headache, weakness, speech difficulties, or visual changes. Prompt evaluation is critical to minimize brain damage. Contact a healthcare provider for any new or worsening neurological symptoms, even if they resolve spontaneously.

Tips for Medical Coders

Document the specific type of cerebral vascular involvement (e.g., ischemic stroke, hemorrhage) and any associated symptoms or complications. Ensure clinical documentation supports the diagnosis and differentiates this code from other sickle-cell subtypes. Include details about diagnostic tests, treatments, and follow-up care to support accurate coding and reimbursement.

Book a walkthrough

D57.813 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.